The prognostic significance of microRNA-221 in hepatocellular carcinoma: An updated meta-analysis

1. Bray, F, Ferlay, J, Soerjomataram, I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394–424.
Google Scholar | Crossref | Medline2. Rahmani, J, Varkaneh, HK, Kontogiannis, V, et al. Waist circumference and risk of liver cancer: a systematic review and meta-analysis of over 2 million cohort study participants. Liver Cancer 2020; 9(1): 6–14.
Google Scholar | Crossref | Medline3. Chen, JG, Zhang, SW. Liver cancer epidemic in China: past, present and future. Semin Cancer Biol 2011; 21(1): 59–69.
Google Scholar | Crossref4. Zayeri, F, Sheidaei, A, Mansouri, A. Clustering Asian and North African countries according to trend of colon and rectum cancer mortality rates: an application of growth mixture models. Asian Pac J Cancer Prev 2015; 16(9): 4115–4121.
Google Scholar | Crossref5. Kumar, S, Fayaz, F, Pottoo, FH, et al. Nanophytomedicine based novel therapeutic strategies in liver cancer. Curr Top Med Chem 2020; 20(22): 1999–2024.
Google Scholar | Crossref6. Gambari, R, Brognara, E, Spandidos, DA, et al. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: new trends in the development of miRNA therapeutic strategies in oncology (review). Int J Oncol 2016; 49(1): 5–32.
Google Scholar | Crossref7. Sandiford, OA, Moore, CA, Du, J, et al. Human aging and cancer: role of miRNA in tumor microenvironment. Adv Exp Med Biol 2018; 10(6): 137–152.
Google Scholar | Crossref8. Fang, Y, Xue, JL, Shen, Q, et al. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology 2012; 55(6): 1852–1862.
Google Scholar | Crossref9. Lee, YG, Kim, I, Oh, S, et al. Small RNA sequencing profiles of mir-181 and mir-221, the most relevant microRNAs in acute myeloid leukemia. Korean J Intern Med 2019; 34(1): 178–183.
Google Scholar | Crossref | Medline10. Liu, X, Yu, J, Jiang, L, Wang, A, et al. MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. Cancer Genomics Proteomics 2009; 6(3): 131–139.
Google Scholar | Medline11. Tsikrika, FD, Avgeris, M, Levis, PK, et al. miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients’ risk for short-term relapse and progression. Genes Chromosomes Cancer 2018; 57(3): 150–161.
Google Scholar | Crossref12. Fornari, F, Pollutri, D, Patrizi, C, et al. In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3-mediated apoptosis. Clin Cancer Res 2017; 23(14): 3953–3965.
Google Scholar | Crossref13. Motawi, TM, Sadik, NA, Shaker, OG, et al. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women. Gene 2016; 590(2): 210–219.
Google Scholar | Crossref14. Brognara, E, Fabbri, E, Bazzoli, E, et al. Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221. J Neurooncol 2014; 118(1): 19–28.
Google Scholar | Crossref | Medline15. Braconi, C, Patel, T. MicroRNA expression profiling: a molecular tool for defining the phenotype of hepatocellular tumors. Hepatology 2008; 47(6): 1807–1809.
Google Scholar | Crossref16. Moher, D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6(7): e1000097.
Google Scholar | Crossref | Medline | ISI17. Stang, A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25(9): 603–605.
Google Scholar | Crossref18. Chen, F, Li, XF, Fu, DS, et al. Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma. Cancer Biomark 2017; 18(2): 209–214.
Google Scholar | Crossref | Medline19. Gramantieri, L, Fornari, F, Ferracin, M, et al. MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res 2009; 15(16): 5073–5081.
Google Scholar | Crossref20. Gyöngyösi, B, Végh, É, Járay, B, et al. Pretreatment MicroRNA level and outcome in Sorafenib-treated hepatocellular carcinoma. J Histochem Cytochem 2014; 62(8): 547–555.
Google Scholar | SAGE Journals21. Karakatsanis, A, Papaconstantinou, I, Gazouli, M, et al. Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog 2013; 52(4): 297–303.
Google Scholar | Crossref22. Li, J, Wang, Y, Yu, W, et al. Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. Biochem Biophys Res Commun 2011; 406(1): 70–73.
Google Scholar | Crossref23. Li, T, Li, M, Hu, S, et al. MiR-221 mediates the epithelial-mesenchymal transition of hepatocellular carcinoma by targeting AdipoR1. Int J Biol Macromol 2017; 103(1): 1054–1061.
Google Scholar | Crossref24. Rong, M, Chen, G, Dang, Y. Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro. BMC Cancer 2013; 13(1): 21.
Google Scholar | Crossref25. Xie, D, Yuan, P, Wang, D, et al. Expression and prognostic significance of miR-375 and miR-221 in liver cancer. Oncol Lett 2017; 14(2): 2305–2309.
Google Scholar | Crossref | Medline26. Yoon, SO, Chun, SM, Han, EH, et al. Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma. Hum Pathol 2011; 42(10): 1391–1400.
Google Scholar | Crossref27. Kannan, M, Jayamohan, S, Moorthy, RK, et al. AEG-1/miR-221 axis cooperatively regulates the progression of hepatocellular carcinoma by targeting PTEN/PI3 K/AKT signaling pathway. Int J Mol Sci 2019; 20(22): 5526.
Google Scholar | Crossref28. Fu, Y, Liu, M, Li, F, et al. MiR-221 promotes hepatocellular carcinoma cells migration via targeting PHF2. Biomed Res Int 2019; 2019(1): 4371405.
Google Scholar29. Li, F, Wang, F, Zhu, C, et al. miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker. Int J Nanomedicine 2018; 13(1): 2295–2307.
Google Scholar | Crossref30. Fornari, F, Gramantieri, L, Ferracin, M, et al. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 2008; 27(43): 5651–5661.
Google Scholar | Crossref | Medline | ISI31. Pineau, P, Volinia, S, McJunkin, K, et al. miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A 2010; 107(1): 264–269.
Google Scholar | Crossref32. Garofalo, M, Di Leva, G, Romano, G, et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 2009; 16(6): 498–509.
Google Scholar | Crossref | Medline | ISI33. Huang, S, Zhou, D, Li, YX, et al. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3. J Cell Physiol 2019; 234(4): 3500–3514.
Google Scholar | Crossref34. Yuan, Q, Loya, K, Rani, B et al. MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration. Hepatology 2013; 57(1): 299–310.
Google Scholar | Crossref35. Chen, JJ, Tang, YS, Huang, SF, et al. HBx protein-induced upregulation of microRNA-221 promotes aberrant proliferation in HBV-related hepatocellular carcinoma by targeting estrogen receptor-α. Oncol Rep 2015; 33(2): 792–798.
Google Scholar | Crossref36. Dai, R, Li, J, Liu, Y, et al. miR-221/222 suppression protects against endoplasmic reticulum stress-induced apoptosis via p27(Kip1)- and MEK/ERK-mediated cell cycle regulation. Biol Chem 2010; 391(1): 791–801.
Google Scholar37. Santhekadur, PK, Das, SK, Gredler, R, et al. Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221. J Biol Chem 2012; 287(17): 13952–13958.
Google Scholar | Crossref38. Liu, Z, Wang, C, Jiao, X, et al. miR-221 promotes growth and invasion of hepatocellular carcinoma cells by constitutive activation of NFκB. Am J Transl Res 2016; 8(11): 4764–4777.
Google Scholar | Medline

留言 (0)

沒有登入
gif